Wentao Han | Medicine | Best Researcher Award

Dr. Wentao Han | Medicine | Best Researcher Award

Dr. Wentao Han, Department of Ophthalmology, The Second Xiangya Hospital, Central South University, China

Wentao Han is a dedicated ophthalmology researcher specializing in diabetic eye complications, dry eye syndrome, and gene therapy. Currently pursuing his research at the Second Xiangya Hospital of Central South University, China, he has demonstrated a strong passion for advancing medical science through innovative studies. His contributions to ocular disease research, particularly in understanding the gut-eye axis and corneal wound healing, highlight his interdisciplinary approach. He has authored multiple high-impact journal articles and actively collaborates with global scholars. His research on machine learning applications in medical diagnosis showcases his forward-thinking vision in integrating AI with healthcare. Beyond academia, Wentao Han serves as a reviewer for prestigious journals, contributing to the integrity of scientific publications. His dedication to translational medicine and biomarker identification continues to shape new therapeutic strategies. His work aims to bridge laboratory findings with clinical applications, improving patient outcomes in ophthalmology and metabolic diseases.

Professional Profile 

Orcid

Suitability for the Research for Best Researcher Award – Wentao Han

Wentao Han demonstrates a strong research background in ophthalmology, particularly in the areas of diabetic eye complications, dry eye syndrome, and corneal wound healing. Currently pursuing research at the Second Xiangya Hospital of Central South University, he has made notable contributions to the field, with multiple high-impact publications in reputable journals. His expertise in the “gut metabolites–inflammation–eye axis” and gene therapy for Meibomian Gland Dysfunction (MGD) highlights his innovative approach to addressing critical challenges in ophthalmology.

His publication record is impressive, with multiple papers in Q1 and Q2 journals, including Pharmaceutics, The Ocular Surface, Acta Diabetologica, and Journal of Medical Internet Research. Notably, his work on machine learning prediction models, autophagy in retinal precursor cells, and the gut-eye axis showcases a multidisciplinary research approach. His role as an invited reviewer for respected journals further establishes his credibility in the academic community.

🎓 Education 

Wentao Han is currently pursuing advanced medical research at Central South University, Changsha, China, within the Department of Ophthalmology at the Second Xiangya Hospital. His academic journey reflects a deep commitment to ophthalmic research, focusing on diabetic retinopathy, ocular surface disorders, and corneal healing mechanisms. Through rigorous training and hands-on experience in clinical settings, he has honed his expertise in evidence-based medicine and translational research. His coursework and mentorship under leading ophthalmologists have allowed him to integrate molecular biology with patient-centered investigations. Additionally, he actively participates in research seminars, workshops, and scientific collaborations, reinforcing his knowledge of bioinformatics, gene therapy, and regenerative medicine. His strong foundation in medical sciences, combined with a keen interest in technological advancements, positions him as a promising young researcher in ophthalmology. His education has equipped him with critical skills to contribute to groundbreaking discoveries in the field of ocular diseases.

💼 Professional Experience 

As a researcher in ophthalmology at the Second Xiangya Hospital of Central South University, Wentao Han has contributed significantly to understanding diabetic eye complications and ocular disease mechanisms. His professional experience includes conducting clinical and preclinical studies on dry eye syndrome, corneal wound healing, and the gut-eye axis. He has extensive expertise in meta-analyses, molecular diagnostics, and the application of artificial intelligence in disease prediction. His work in identifying novel biomarkers for diabetic retinopathy has been widely recognized. Additionally, he collaborates with interdisciplinary teams, integrating bioinformatics and evidence-based medicine to develop innovative treatment approaches. Han’s active involvement in academic publishing and peer review for high-impact journals reflects his commitment to advancing medical knowledge. His current projects involve investigating gene therapy for meibomian gland dysfunction and corneal regeneration, with the aim of translating scientific discoveries into clinical applications that enhance patient care in ophthalmology.

🏅 Awards and Recognition 

Wentao Han has received multiple recognitions for his outstanding contributions to ophthalmic research. He has been an invited reviewer for prestigious journals such as Cell Death Discovery (IF = 7) and Acta Diabetologia (IF = 3.9), underscoring his expertise in diabetes-related ocular disorders. His research on gut metabolites’ role in eye diseases has been acknowledged at international conferences. Several of his published articles in Q1 journals have earned high citations, reflecting their impact on the scientific community. Han has also contributed to the development of machine learning prediction models for gestational diabetes mellitus, further showcasing his interdisciplinary proficiency. His involvement in groundbreaking studies on corneal wound healing has positioned him as a promising young researcher in ophthalmology. With a strong publication record, peer recognition, and contributions to medical advancements, Han continues to be a driving force in translational ophthalmic research and clinical innovation.

🌍 Research Skills On Medicine

Wentao Han possesses a diverse set of research skills that bridge molecular biology, clinical medicine, and artificial intelligence applications in ophthalmology. His expertise includes conducting systematic reviews, meta-analyses, and experimental research on diabetic retinopathy and dry eye syndrome. He is proficient in bioinformatics tools for gene analysis and biomarker identification, which he applies to precision medicine. Han is skilled in laboratory techniques such as immunohistochemistry, cell culture, and animal models for ocular disease studies. His ability to integrate AI and machine learning into medical research has led to innovative predictive models for disease diagnosis. Additionally, his work in gene therapy for corneal and meibomian gland dysfunction highlights his translational research capabilities. Han’s interdisciplinary approach allows him to explore novel therapeutic targets, making significant contributions to evidence-based medicine. His research aims to improve diagnostic accuracy and therapeutic interventions in ophthalmic and metabolic disorders.

📖 Publication Top Notes

  • Research Progress and Potential Applications of Spermidine in Ocular Diseases
  • Machine Learning Prediction Models for Gestational Diabetes Mellitus: Meta-analysis
    • Authors: Zheqing Zhang, Luqian Yang, Wentao Han, Yaoyu Wu, Linhui Zhang, Chun Gao, Kui Jiang, Yun Liu, Huiqun Wu
    • Citation: Journal of Medical Internet Research, 2022-03-16
    • Year: 2022
    • DOI: 10.2196/26634
  • Genome Analysis and Identification of Key Pathway in Visceral Adipose Tissue from Obesity-Related Diabetes
    • Authors: Wentao Han
    • Citation: Proceedings of the 2021 International Conference on Bioinformatics and Intelligent Computing, 2021-01-22
    • Year: 2021
    • DOI: 10.1145/3448748.3448757
  • Machine Learning Prediction Models for Gestational Diabetes Mellitus: Meta-analysis (Preprint)
    • Authors: Zheqing Zhang, Luqian Yang, Wentao Han, Yaoyu Wu, Linhui Zhang, Chun Gao, Kui Jiang, Yun Liu, Huiqun Wu
    • Citation: Preprint, 2020-12-19
    • Year: 2020
    • DOI: 10.2196/preprints.26634
  • Construction of a Knowledge Graph for Diabetes Complications from Expert-Reviewed Clinical Evidences
    • Authors: Wentao Han
    • Citation: Computer Assisted Surgery (Abingdon, England), 2020-11-25
    • Year: 2020
    • DOI: 10.1080/24699322.2020.1850866
    • PMID: 33275462
  • Association Between Retinol Binding Protein 4 and Diabetic Retinopathy Among Type 2 Diabetic Patients: A Meta-analysis
    • Authors: Wentao Han, Huagen Wei, Weizheng Kong, Jing Wang, Luqian Yang, Huiqun Wu
    • Citation: Acta Diabetologica, 2020-10
    • Year: 2020
    • DOI: 10.1007/s00592-020-01535-3

 

Scheherazade Le | Neuroscience | Best Researcher Award

Dr. Scheherazade Le | Neuroscience | Best Researcher Award

👤 Dr. Scheherazade Le, Stanford, United States

Dr. Scheherazade Le, M.D., is a Clinical Professor in the Department of Neurology at Stanford University. With expertise in epilepsy and electroencephalography (EEG), she specializes in intraoperative neuromonitoring (IONM) and neurophysiology. Dr. Le earned her M.D. from the University of California, San Francisco (UCSF), and completed residency and fellowship training at Stanford University, where she also held the role of Chief Resident. With extensive clinical and academic appointments, Dr. Le is dedicated to advancing medical education in neurology. Her contributions extend to the creation of high-quality teaching curricula and the mentorship of students, residents, and fellows. Her clinical expertise and passion for education have earned her multiple honors, including the A.B. Baker Teacher Recognition Award. Through her innovative teaching and research, Dr. Le has made significant contributions to the field of neuroscience.

Professional Profile

Scopus

🌟 Research for Best Researcher Award Evaluation for Dr. Scheherazade Le, M.D.

Dr. Scheherazade Le, a Clinical Professor in the Department of Neurology at Stanford University, is an exemplary candidate for the Research for Best Researcher Award. Her extensive background in epilepsy, electroencephalography (EEG), and intraoperative neuro-monitoring (IONM) sets her apart as a leader in the field. She holds dual board certifications in adult neurology and epilepsy, which reflect her comprehensive expertise.

Dr. Le’s education and training at prestigious institutions like UCSF and Stanford, coupled with her multiple academic appointments and contributions to the curriculum, have been highly influential. Her role as the co-course director of Stanford’s Neuroscience Block and her efforts in developing innovative neurology curriculum, especially for epilepsy, reflect her deep commitment to advancing education in the medical field. She has consistently received recognition for her excellence in teaching, receiving numerous awards such as the A.B. Baker Teacher Recognition Award from the American Academy of Neurology in 2024.

🎓 Education 

Dr. Scheherazade Le completed her M.D. at the University of California, San Francisco (UCSF) in May 2006, where she focused on medical humanities. Her undergraduate studies were at the University of California, Berkeley (UCB), where she graduated with High Honors in Political Science and received the highest honors for her thesis. Dr. Le pursued residency in Neurology at Stanford University, where she also served as Chief Resident. Afterward, she completed fellowship training in Clinical Neurophysiology at Stanford, specializing in Intraoperative Neuro-Monitoring (IONM) and Epilepsy & Electroencephalography (EEG). Dr. Le’s academic achievements are reflected in her continuous commitment to excellence in teaching and mentoring. She has significantly contributed to shaping the neurology curriculum at Stanford Medical School and has earned numerous awards, such as the A.B. Baker Teacher Recognition Award, further demonstrating her academic prowess and passion for education.

💼   Professional Experience 

Dr. Scheherazade Le currently serves as a Clinical Professor at the Department of Neurology at Stanford University, where she is responsible for teaching and supervising medical students, residents, and fellows in epilepsy, electroencephalography (EEG), and intraoperative neuromonitoring (IONM). Her professional trajectory includes various roles at Stanford University, ranging from Clinical Assistant Professor to Clinical Associate Professor. Throughout her tenure, she has led educational initiatives and clinical training for Stanford’s Neurology residency and fellowship programs. Dr. Le has been instrumental in course development for the Neuroscience Block (SOM223A), a second-year medical school course that she co-directs. She is also an invited lecturer for the Stanford Physician Assistant Program and actively participates in the Epilepsy Monitoring Unit. Dr. Le’s clinical work involves treating patients with epilepsy, neurophysiological conditions, and neurological disorders, while her academic efforts focus on curriculum development and innovative teaching methodologies.

🏅  Awards and Recognition 

Dr. Scheherazade Le has been recognized with numerous prestigious awards throughout her career. She was nominated for the American Academy of Neurology (AAN) Neuroscience Course Director Excellence Award in 2025 and received the A.B. Baker Teacher Recognition Award in 2024. Her commitment to educational excellence is further demonstrated by her receipt of the Stanford School of Medicine’s highest-rated course award for the Neuroscience Block (SOM223), which she has received multiple times, including in 2023 and 2024. Dr. Le’s work in neurology education also garnered her the Henry J. Kaiser Family Foundation Teaching Award Nominee for her contributions to medical education from 2022 to 2023. Other accolades include the Stanford Department of Neurology Lysia S. Forno Teaching Award and the Stanford Neurology Clerkship Medical Student Teaching Award. These honors reflect her dedication to advancing both the academic and clinical training of the next generation of neurologists.

🌍 Research Skill On Neuroscience

Dr. Scheherazade Le’s research interests lie at the intersection of clinical neurophysiology, epilepsy, and neuroimaging. She is particularly focused on advancing understanding and treatment methodologies for epilepsy and neurologic diseases through the use of electroencephalography (EEG) and intraoperative neuro-monitoring (IONM). Dr. Le’s research has contributed to the growing body of knowledge regarding brain-responsive neurostimulation in epilepsy patients with tuberous sclerosis complex. Additionally, she has been involved in studies concerning autoimmune encephalitis, psychogenic non-epileptic seizures, and the neurophysiology of abnormal movements. Her ability to bridge clinical practice with scientific investigation allows her to translate complex research findings into effective clinical treatments. Dr. Le is a key collaborator in multi-disciplinary research projects and has presented her work at regional neurophysiology and neuroimmunology conferences. Her ongoing research aims to improve diagnostic approaches and develop innovative therapies for neurological disorders, impacting both clinical practice and patient care.

 📖 Publication Top Notes

  • Cognitive and behavioral effects of perampanel 4 mg daily dose
    Authors: Meador, K.J., Seliger, J., Le, S., Loring, D.W., Gerard, E.
    Journal: Epilepsy and Behavior
    Year: 2025
    Volume: 164
  • Response to “Antipsychotics use in autoimmune encephalitis and multiple sclerosis: Impact on hospitalization duration”
    Authors: Folmsbee, S.S., Gombar, S., Le, S.
    Journal: Journal of Clinical Neuroscience
    Year: 2024
    Volume: 126
  • Amnesia, Superior Altitudinal Anopia, and Reversed Clock Phenomenon due to Bilateral Posterior Cerebral Artery Infarcts
    Authors: Jindal, J.A., Le, S.T., Lansberg, M.G.
    Journal: Stroke
    Year: 2024
    Volume: 55(6)
  • Antipsychotic medications associated with increased length of hospital stay in autoimmune encephalitis and multiple sclerosis: A retrospective study
    Authors: Sai Folmsbee, S., Hui, G., Yuan, Y., Han, M., Le, S.
    Journal: Journal of Clinical Neuroscience
    Year: 2024
    Volume: 124
  • Utilization of APE2 and RITE2 scores in autoimmune encephalitis patients with seizures
    Authors: Rafferty, T., Koeppen-Babcock, A., Muppidi, S., Li, Y., Le, S.
    Journal: Epilepsy and Behavior
    Year: 2024
    Volume: 154
  • Long-term outcomes of mesial temporal laser interstitial thermal therapy for drug-resistant epilepsy and subsequent surgery for seizure recurrence: A multi-centre cohort study
    Authors: Youngerman, B.E., Banu, M.A., Khan, F., D’Haese, P.-F., Wu, C.
    Journal: Journal of Neurology, Neurosurgery and Psychiatry
    Year: 2023
    Volume: 94(11)
  • Sharps Injuries Related to Subdermal Needles in the Orbicularis Oris During Intraoperative Neurophysiologic Monitoring
    Authors: Joshi, A., Aissa, Y., Le, S., Lee, L., Lopez, J.R.
    Journal: Journal of Clinical Neurophysiology
    Year: 2022
    Volume: 39(7)
  • A retrospective cohort study of new-onset refractory status epilepticus (NORSE): clinical features, timing of immunotherapy and outcomes
    Authors: Werbaneth, K., Mausolf, M., Seliger, J., Le, S.
    Journal: Epileptic Disorders
    Year: 2022
    Volume: 24(5)
  • Direct brainstem somatosensory evoked potentials for cavernous malformations
    Authors: Le, S., Nguyen, V., Lee, L., Steinberg, G., López, J.
    Journal: Journal of Neurosurgery
    Year: 2022
    Volume: 137(1)
  • Hybrid Fluoroscopic and Neurophysiological Targeting of Responsive Neurostimulation of the Rolandic Cortex
    Authors: Parker, J.J., Jamiolkowski, R.M., Grant, G.A., Le, S., Halpern, C.H.
    Journal: Operative Neurosurgery
    Year: 2021
    Volume: 21(3)

Ebru Afşar | Neuroscience | Best Researcher Award

Dr. Ebru Afşar | Neuroscience | Best Researcher Award

👤 Dr. Ebru Afşar, Cappadoccia Univercıty, Turkey

Ebru Afşar, born on June 15, 1986, in Kayseri/Tomarza, is a distinguished academic and researcher. She is currently a faculty member at Kapadokya University, specializing in Medical Biochemistry at the Faculty of Dentistry. Ebru’s academic journey began with a bachelor’s degree in Biology from Afyon Kocatepe University, followed by a Master’s degree in Microbiology and Clinical Microbiology. She continued her studies with another Master’s in Medical Biochemistry at Akdeniz University and completed her Ph.D. in the same field. Ebru’s extensive teaching experience includes courses in biochemistry, microbiology, and pathology, with a focus on nutrition and dietetics. Throughout her career, she has actively participated in numerous national and international congresses and training programs, enriching her expertise. Her passion for research and education drives her to contribute significantly to the academic world.

Professional Profile

Orcid

🌟 Suitability of Ebru Afşar for the Research for Best Researcher Award

Ebru Afşar’s academic background and professional experience position her as a highly suitable candidate for the “Research for Best Researcher Award.” Her educational journey, beginning with a bachelor’s degree in Biology and progressing through a master’s and doctorate in Medical Biochemistry, illustrates a strong foundation in scientific research. Ebru’s expertise in microbiology, clinical microbiology, and medical biochemistry demonstrates her commitment to the life sciences, particularly in the areas of healthcare and disease mechanisms.

Her career includes a mix of research roles and teaching positions. At Akdeniz University, where she worked as a research assistant and later as an academic member in the Department of Medical Biochemistry, Ebru displayed a clear aptitude for scientific inquiry. Since transitioning to Kapadokya University in 2023 as an academic member in the Faculty of Dentistry, her interdisciplinary knowledge and growing teaching responsibilities reflect her commitment to advancing her field and mentoring the next generation of scientists. Her teaching portfolio spans various disciplines, including biochemistry, clinical microbiology, and nutrition biochemistry, further highlighting her breadth of expertise.

 🎓 Education 

Ebru Afşar’s educational journey is rooted in rigorous academic training. She graduated with a bachelor’s degree in Biology from Afyon Kocatepe University in 2007, with a GPA of 2.78. She then pursued a Master’s degree in Microbiology and Clinical Microbiology at the same university, earning a GPA of 2.93 in 2010. Ebru continued her academic progression at Akdeniz University, where she completed a Master’s in Medical Biochemistry in 2015, with a GPA of 3.12. Building on her strong foundation, she completed her Ph.D. in Medical Biochemistry in 2021, achieving a GPA of 3.56. Throughout her studies, Ebru demonstrated a commitment to excellence in her field, preparing her for a successful career in both teaching and research. Her academic achievements reflect her dedication to advancing the field of biochemistry and her role as a mentor to future generations of students.

💼 Professional Experience 

Ebru Afşar’s professional career spans both academic teaching and research. Since March 2018, she has been an academic member of the Medical Biochemistry Department at Akdeniz University, contributing significantly to the institution’s research output. She then transitioned to Istanbul Kültür University in 2021 as a faculty member in the Department of Nutrition and Dietetics, where she remained until March 2023. Ebru currently serves as a faculty member at Kapadokya University in the Faculty of Dentistry. Her professional journey is marked by her active involvement in teaching various biochemistry and microbiology courses across multiple disciplines, including nutrition, dietetics, nursing, and physiotherapy. Her expertise in medical biochemistry has enabled her to bridge the gap between theoretical knowledge and practical applications in clinical settings. Ebru’s ongoing contributions to academic and research fields continue to shape the future of medical education and biochemical sciences.

🏅 Awards and Recognition

Ebru Afşar has received several recognitions throughout her academic and professional career. Her dedication to advancing knowledge and contributing to scientific communities is reflected in her participation in various national and international congresses, including the “Clinical Biochemistry Specialists Congress” in 2014 and the “1st National Proteomics Congress” in Antalya. She also received a certification in Animal Experimentation from Akdeniz University in 2014. These awards and recognitions are a testament to her hard work and commitment to excellence in her field. Her expertise in medical biochemistry and her active participation in academic conferences have earned her a reputable standing in the scientific community. Ebru is also recognized for her contributions to student education, evidenced by her role in various teaching and mentoring programs across universities.

🌍  Research Skills On Neuroscience

Ebru Afşar has developed a comprehensive set of research skills throughout her academic and professional journey. Her expertise in medical biochemistry, microbiology, and clinical laboratory techniques has been honed through her extensive research experience. Ebru’s work is focused on biochemical processes, clinical biochemistry, and molecular biology, particularly in the fields of nutrition and disease pathology. She has utilized advanced techniques such as mass spectrometry, proteomics, and clinical diagnostics to further her research. Her ability to design and conduct research projects, along with her proficiency in using various analytical tools, has contributed to a deeper understanding of biochemical processes. Ebru’s research skills extend to data analysis, statistical methods, and presenting her findings through academic publications. Her ability to collaborate across disciplines and contribute to the advancement of scientific knowledge makes her a valuable researcher in her field.

📖 Publication Top Notes

  • Title: ARI EKMEĞİNİN ALZHEİMER SIÇAN MODELİNDE KARACİĞER 5HT2B ARACILI GLUKOZ DÜZENLEMESİ ÜZERİNE ETKİSİ
    Authors: Ebru Afşar, Kadirhan Doğan, Deniz Kantar Gül, Alev Duygu Kuzzu
    Citation: Kocatepe Tıp Dergisi, 2024-10-21
    DOI: 10.18229/kocatepetip.1433727
  • Title: Anxiolytic-like effects of extremely low frequency electric field in stressed rats: involvement of 5-HT2C receptors
    Authors: Deniz Kantar, Alev Duygu Acun, Hakan Er, Ebru Afsar, Piraye Yargıcoglu
    Citation: International Journal of Radiation Biology, 2023-09-02
    DOI: 10.1080/09553002.2022.2087929